Fig. 6
From: Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling
Clinical relevance of miR-29a in breast cancer patients. A, B Negative correlations between the overall survival rate and the miR-29a level in breast cancer patients with either distant metastasis (M1 stage) (A) or lymph node metastasis (N1-N3) (B). C A negative correlation between the disease specific survival and the miR-29a level in breast cancer patients with lymph node metastasis (N1-N3). In contrast, breast cancer patients without metastasis (M0 or N0 stages) showed positive correlations between the survival rate and miR-29a expression. The TCGA database was used for analysis